vs
American Assets Trust, Inc.（AAT）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是American Assets Trust, Inc.的1.8倍（$197.9M vs $110.6M），REPLIGEN CORP净利率更高（6.7% vs 6.1%，领先0.6%），REPLIGEN CORP同比增速更快（13.6% vs 1.8%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -0.1%）
该公司是一家大型英国投资信托，在伦敦证券交易所上市，同时是富时250指数的成分股，现任董事长为获颁CBE勋章的伊恩·弗格森。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
AAT vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.8倍
$110.6M
营收增速更快
RGEN
高出11.8%
1.8%
净利率更高
RGEN
高出0.6%
6.1%
两年增速更快
RGEN
近两年复合增速
-0.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $110.6M | $197.9M |
| 净利润 | $6.7M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 23.4% | 9.0% |
| 净利率 | 6.1% | 6.7% |
| 营收同比 | 1.8% | 13.6% |
| 净利润同比 | -16.3% | 143.9% |
| 每股收益（稀释后） | $0.08 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AATRGEN
| Q1 26 | $110.6M | — | ||
| Q4 25 | $110.1M | $197.9M | ||
| Q3 25 | $109.6M | $188.8M | ||
| Q2 25 | $107.9M | $182.4M | ||
| Q1 25 | $108.6M | $169.2M | ||
| Q4 24 | $113.5M | $174.1M | ||
| Q3 24 | $122.8M | $154.9M | ||
| Q2 24 | $110.9M | $154.1M |
净利润AATRGEN
| Q1 26 | $6.7M | — | ||
| Q4 25 | — | $13.3M | ||
| Q3 25 | $4.5M | $14.9M | ||
| Q2 25 | $5.5M | $14.9M | ||
| Q1 25 | $42.5M | $5.8M | ||
| Q4 24 | — | $-30.3M | ||
| Q3 24 | $16.7M | $-654.0K | ||
| Q2 24 | $11.9M | $3.3M |
毛利率AATRGEN
| Q1 26 | — | — | ||
| Q4 25 | 59.4% | 52.5% | ||
| Q3 25 | 60.5% | 53.2% | ||
| Q2 25 | 62.6% | 50.0% | ||
| Q1 25 | 62.0% | 53.6% | ||
| Q4 24 | 61.3% | 26.1% | ||
| Q3 24 | 65.5% | 50.0% | ||
| Q2 24 | 63.6% | 49.8% |
营业利润率AATRGEN
| Q1 26 | 23.4% | — | ||
| Q4 25 | 21.1% | 9.0% | ||
| Q3 25 | 22.6% | 8.9% | ||
| Q2 25 | 24.1% | 7.6% | ||
| Q1 25 | 66.3% | 3.9% | ||
| Q4 24 | 26.5% | -17.7% | ||
| Q3 24 | 30.8% | -5.1% | ||
| Q2 24 | 27.8% | 1.0% |
净利率AATRGEN
| Q1 26 | 6.1% | — | ||
| Q4 25 | — | 6.7% | ||
| Q3 25 | 4.1% | 7.9% | ||
| Q2 25 | 5.1% | 8.2% | ||
| Q1 25 | 39.2% | 3.4% | ||
| Q4 24 | — | -17.4% | ||
| Q3 24 | 13.6% | -0.4% | ||
| Q2 24 | 10.7% | 2.2% |
每股收益（稀释后）AATRGEN
| Q1 26 | $0.08 | — | ||
| Q4 25 | $0.06 | $0.24 | ||
| Q3 25 | $0.07 | $0.26 | ||
| Q2 25 | $0.09 | $0.26 | ||
| Q1 25 | $0.70 | $0.10 | ||
| Q4 24 | $0.14 | $-0.55 | ||
| Q3 24 | $0.28 | $-0.01 | ||
| Q2 24 | $0.20 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $118.3M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.1B | $2.1B |
| 总资产 | $2.9B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资AATRGEN
| Q1 26 | $118.3M | — | ||
| Q4 25 | $129.4M | $767.6M | ||
| Q3 25 | $138.7M | $748.7M | ||
| Q2 25 | $143.7M | $708.9M | ||
| Q1 25 | $143.9M | $697.2M | ||
| Q4 24 | $425.7M | $757.4M | ||
| Q3 24 | $533.0M | $784.0M | ||
| Q2 24 | $114.9M | $809.1M |
总债务AATRGEN
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.0B | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益AATRGEN
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.2B | $2.1B | ||
| Q3 25 | $1.2B | $2.1B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.2B | $2.0B | ||
| Q4 24 | $1.2B | $2.0B | ||
| Q3 24 | $1.2B | $2.0B | ||
| Q2 24 | $1.2B | $2.0B |
总资产AATRGEN
| Q1 26 | $2.9B | — | ||
| Q4 25 | $2.9B | $2.9B | ||
| Q3 25 | $2.9B | $2.9B | ||
| Q2 25 | $3.0B | $2.9B | ||
| Q1 25 | $3.0B | $2.9B | ||
| Q4 24 | $3.3B | $2.8B | ||
| Q3 24 | $3.4B | $2.8B | ||
| Q2 24 | $3.0B | $2.9B |
负债/权益比AATRGEN
| Q1 26 | — | — | ||
| Q4 25 | 1.48× | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.72× | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | 14.5% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流AATRGEN
| Q1 26 | — | — | ||
| Q4 25 | $167.1M | $25.7M | ||
| Q3 25 | $40.5M | $48.1M | ||
| Q2 25 | $49.2M | $28.6M | ||
| Q1 25 | $36.9M | $15.0M | ||
| Q4 24 | $207.1M | $39.2M | ||
| Q3 24 | $52.4M | $49.3M | ||
| Q2 24 | $59.3M | $42.2M |
自由现金流AATRGEN
| Q1 26 | — | — | ||
| Q4 25 | $94.9M | $17.6M | ||
| Q3 25 | $23.1M | $43.4M | ||
| Q2 25 | $28.4M | $21.5M | ||
| Q1 25 | $20.4M | $11.4M | ||
| Q4 24 | $136.9M | $33.6M | ||
| Q3 24 | $28.0M | $42.3M | ||
| Q2 24 | $43.6M | $37.4M |
自由现金流率AATRGEN
| Q1 26 | — | — | ||
| Q4 25 | 86.2% | 8.9% | ||
| Q3 25 | 21.1% | 23.0% | ||
| Q2 25 | 26.3% | 11.8% | ||
| Q1 25 | 18.8% | 6.8% | ||
| Q4 24 | 120.7% | 19.3% | ||
| Q3 24 | 22.8% | 27.3% | ||
| Q2 24 | 39.3% | 24.3% |
资本支出强度AATRGEN
| Q1 26 | 14.5% | — | ||
| Q4 25 | 65.6% | 4.1% | ||
| Q3 25 | 15.9% | 2.5% | ||
| Q2 25 | 19.3% | 3.9% | ||
| Q1 25 | 15.1% | 2.1% | ||
| Q4 24 | 61.9% | 3.2% | ||
| Q3 24 | 19.9% | 4.5% | ||
| Q2 24 | 14.1% | 3.1% |
现金转化率AATRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | 8.98× | 3.23× | ||
| Q2 25 | 9.01× | 1.92× | ||
| Q1 25 | 0.87× | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.15× | — | ||
| Q2 24 | 4.98× | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AAT
| Rental income | $104.4M | 94% |
| Other | $6.2M | 6% |
RGEN
暂无分部数据
